Tirzepatide is a new medication that was FDA approved in May 2022 to treat Type 2 diabetes. It’s a once-weekly injection. When used along with diet and lifestyle changes, it can help lower blood sugar (glucose) levels. People taking it also tend to lose weight.
In addition to treating Type 2 diabetes, tirzepatide has been shown to help with weight loss in people without diabetes. A clinical trial of over 2,500 people with obesity or overweight experienced significant weight loss with weekly tirzepatide. Those treated with tirzepatide had an average weight loss of 15% to 20% of their starting body weight over 72 weeks (about 16 and a half months). Those taking the placebo (an injection with no medication in it) only had an average of 3% weight loss.
Since I started taking semaglutide, I feel less hungry, I get full faster and more importantly - I've lost weight! Excited for the future!Eva P. Real Patient